Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Theratechnologies Inc
T.TH
Alternate Symbol(s):
THTX
Healthcare
Biotechnology
Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs...
in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
TSX:TH - Post Discussion
Theratechnologies Inc
> Links to Filings
New Post
View:
Discussion
List
(198)
•••
palinc2000
X
View Profile
View Bullboard History
Post by
palinc2000
on Jul 26, 2021 8:00am
Links to Filings
https://www.theratech.com/node/11726/html
https://www.theratech.com/node/11731/html
(34)
•••
Wino115
X
View Profile
View Bullboard History
Comment by
Wino115
on Jul 26, 2021 9:33am
Thanks for posting. I see nothing new in any business updates and the use of proceeds is the vague list of all their expense lines - R&D, SG&A, general Corp, etc.... So we have to assume that the pressure we have applied and that they have acknowledged to get a serious biotech analyst in the US to cover them in their entirety is one reason they've done this. I
...more
(198)
•••
palinc2000
X
View Profile
View Bullboard History
Comment by
palinc2000
on Jul 26, 2021 9:39am
50 million $ is a lot of money for a small bio...If somehow the ATM does not create more than 10% dilution I will be ok,,,,,
(258)
•••
qwerty22
X
View Profile
View Bullboard History
Comment by
qwerty22
on Jul 26, 2021 10:05am
I have more questions for you. 1) Do you think it's 100% Cantor will do a research report given this news? 2) Does Cantor picking this up 'legitimize' thtx with other analysts? Do analysts read other analysts reports? Might they be motivated by the opportunity or is it always just about $$$? Is getting the first one always the hardest? Is this about getting the ball
...more
(34)
•••
Wino115
X
View Profile
View Bullboard History
Comment by
Wino115
on Jul 26, 2021 12:39pm
Unfortunately, on Wall St you can never say 100% and there would be plenty of perfectly legitimate reasons their analysts declines. Maybe we should use 60%yes/40%no? It makes sense that they would, but it's definitely not 100%. Others may know more and can tilt those odds. Reading between the lines I would hope that was a thought and I recall management talking about
...more
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
New electric industrial heat technology to reduce greenhouse gas emissions
Discover Options Trading Strategies to Minimize your Tax Burden
Learn About a Mining Portfolio of More Than 250 Projects and Royalties Across North America
Have you held units of a TD mutual fund (other than through a discount broker)? Learn more.
The Many Indications that the Gold and Silver Sector is on the Verge of a Multi-Year Super Cycle